Search

everythinglearnresearchcommunity

for

Search:↓

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Most hair loss in children is caused by a few common conditions, and it's important to diagnose these properly and support the child's mental health.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Anabolic steroid users may face higher risk of severe COVID-19.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

The first in-prison dermatology clinic in the U.S. faced challenges and found certain skin conditions common among inmates, with rare cases of serious skin cancer.

Dutasteride does not impair mental function in elderly men with enlarged prostate.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Men prefer less invasive cosmetic procedures and need different treatment approaches than women.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Spironolactone might cause painful intercourse and decreased sexual arousal in women.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

New treatments for PCOS focus on managing symptoms and improving fertility.

The document concludes that awareness and understanding of hidradenitis suppurativa are increasing, but effective treatments are still needed.